Literature DB >> 6132105

MHC "supratype" predicting heterozygous 21-hydroxylase deficiency.

J McCluskey, P H Kay, M Stuckey, F T Christiansen, R L Dawkins, G Wilson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6132105     DOI： 10.1016/s0140-6736(83)92050-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  A restriction fragment of the C2 gene is a unique marker for C2 deficiency and the uncommon C2 allele C2*B (a marker for type 1 diabetes).

Authors:  S Simon; Z Awdeh; R D Campbell; P Ronco; S J Brink; G S Eisenbarth; E J Yunis; C A Alper
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

2.  Extensive genomic polymorphism in mouse 21-hydroxylase region.

Authors:  D Gillet; E Mornet; A Rocca; L Degos; D Cohen; M Pla
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

3.  Identification of a new HLA-B7-associated C21-hydroxylase deficiency gene by restriction enzyme length polymorphism.

Authors:  E Keller; A Andreas-Zietz; D Knorr; S Scholz; E D Albert
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

4.  Sharing of MHC haplotypes among apparently unrelated patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Z Layrisse; C White; P Gunczler; L Gafaro Valera; S Arias; E J Yunis; C A Alper; Z L Awdeh
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

5.  MHC Genomics and Disease: Looking Back to Go Forward.

Authors:  Roger L Dawkins; Sally S Lloyd
Journal:  Cells       Date:  2019-08-21       Impact factor: 6.600
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.